Find Funding Opportunities

The purpose of this Notice is to announce that the National Institute of Allergy and Infectious Diseases (NIAID), the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), the National Institute of Mental Health (NIMH), the National Institute of Neurological Disorders and Stroke (NINDS), and the National Center for Complementary and Integrative Health (NCCIH) encourage new applications to advance research activities relevant to the five strategic priorities identified in the recently released NIH Strategic Plan for Tickborne Disease Research:

The purpose of this notice is to inform applicants of a correction to the Eligibility Information for RFA-NS-22-011 "BRAIN Initiative: Research Resource Grants for Technology Integration and Dissemination (U24 Clinical Trial Not Allowed). For this Funding Opportunity Announcement (FOA), "Section III. Eligibility Information" has been corrected to allow intramural participation. This is consistent with the intramural participation language in "Section IV. Application and Submission Information, 7. Other Submission Requirements and Information".

The purpose of this time-sensitive Request for Information (RFI) is to seek input on the Draft ALS Strategic Plan from people living with amyotrophic lateral sclerosis (ALS), families, caregivers, people with genetic risk of ALS, advocates, scientists, clinicians, and the broader community.

On October 11, 2022, the National Institute on Drug Abuse and BRAIN Initiative published the Funding Opportunity Announcement, RFA-DA-23-030, BRAIN Initiative: Brain-Behavior Quantification and Synchronization Transformative and Integrative Models of Behavior at the Organismal Level (R34 Clinical Trial Not Allowed) to solicit applications supporting planning activities that will lay the groundwork for a scientific projects aiming to 1) develop and apply cutting-edge tools and methods for minimally invasive, multi-dimensional, high-resolution measurement of behavior at the level of the organism, with synchronous capture of data from the environment; and/or 2) develop computational methods that allow for integration of multidimensional behavioral and environmental data into a conceptual and/or computational model of behavior as a complex dynamic system. This Notice provides information regarding two upcoming Pre-Application Webinars for the above-referenced FOA. At these Webinars, Program and Review Officials from NIDA and other institutes participating in the BRAIN Initiative will provide a brief overview of this RFA and address questions from prospective applicants. Webinar Information Option 1 Date: Tuesday, November 22, 2022, Time: 11 am EST The webinar will be hosted through Zoom. Participants must register in advance for the webinar through the following link, after which a link to join the webinar will be e-mailed to the participant: NIH Zoom Webinar link: https://scgcorp.zoom.us/meeting/register/tZUkcOGrrj4jGtBm0XWaz_OYurAyDm… Option 2 Date: Monday, November 28, 2022, Time: 1 pm EST The webinar will be hosted through Zoom. Participants must register in advance for the webinar through the following link, after which a link to join the webinar will be e-mailed to the participant: NIH Zoom Webinar link: https://scgcorp.zoom.us/meeting/register/tZIqd-qvrTkrGNE22c1MQMmAdJ8Zf4…

The purpose of this notice is to correct the expiration date for PAR-22-181 "NCCIH, NEI, NIAAA, NIDA, NIMH, NINR, and NINDS Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)".

The purpose of this notice is to extend RFA-NS-22-021 "HEAL Initiative: Human Pain-associated Genes & Cells Data Coordination and Integration Center (U24 Clinical Trial Not Allowed)" by one council round.

The National Institute of Neurological Disorders and Stroke intends to publish a Notice of Special Interest for applications proposing qualifying clinical trials to study epidural stimulation in spinal cord injury. This notice is only for applications submitted to PAR-21-237 NINDS Efficacy Clinical Trials (UG3/UH3 Clinical Trial Required) Funding Opportunity Announcement. This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects.

This Notice is to inform potential applicants that the National Institute of Nursing Research will hold a technical assistance webinar for RFA-NR-23-001 HEAL Initiative: Prevention and Management of Chronic Pain in Rural Populations (UG3/UH3 Clinical Trial Required).

The purpose of this notice is to inform applicants of a correction to the Application and Submission Information for RFA-NS-22-029 "Clinical Coordinating Center for the Network of Excellence in Neuroscience Clinical Trials (NEXT - CCC) (U01 Clinical Trial Not Allowed)".

The purpose of this notice is to remove a sentence related to Appendix Materials in RFA-NS-22-031 "Clinical Research Sites for the Network of Excellence in Neuroscience Clinical Trials (NeuroNEXT sites) (U24 Clinical Trial Not Allowed)".